Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association

J Rangaswami, V Bhalla, JEA Blair, TI Chang, S Costa… - Circulation, 2019 - Am Heart Assoc
Cardiorenal syndrome encompasses a spectrum of disorders involving both the heart and
kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic …

Evidence-based medical therapy in patients with heart failure with reduced ejection fraction and chronic kidney disease

IE Beldhuis, CSP Lam, JM Testani, AA Voors… - Circulation, 2022 - Am Heart Assoc
Chronic kidney disease (CKD) as identified by a reduced estimated glomerular filtration rate
(eGFR) is a common comorbidity in patients with heart failure with reduced ejection fraction …

[HTML][HTML] Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

AA House, C Wanner, MJ Sarnak, IL Piña… - Kidney international, 2019 - Elsevier
The incidence and prevalence of heart failure (HF) and chronic kidney disease (CKD) are
increasing, and as such a better understanding of the interface between both conditions is …

Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials

X **e, Y Liu, V Perkovic, X Li, T Ninomiya… - American Journal of …, 2016 - Elsevier
Background There is much uncertainty regarding the relative effects of angiotensin-
converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in …

Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week

JA Udell, WS Jones, MC Petrie, J Harrington… - Journal of the American …, 2022 - jacc.org
Abstract Sodium glucose cotransporter-2 (SGLT2) inhibitors improve cardiorenal outcomes
in patients with type 2 diabetes mellitus, chronic kidney disease, and chronic heart failure …

Cardiorenal syndrome

C Ronco, M Haapio, AA House, N Anavekar… - Journal of the American …, 2008 - jacc.org
The term cardiorenal syndrome (CRS) increasingly has been used without a consistent or
well-accepted definition. To include the vast array of interrelated derangements, and to …

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST …

JP Bassand, CW Hamm, D Ardissino… - European heart …, 2007 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Heart failure in patients with chronic kidney disease: a systematic integrative review

L Segall, I Nistor, A Covic - BioMed research international, 2014 - Wiley Online Library
Introduction. Heart failure (HF) is highly prevalent in patients with chronic kidney disease
(CKD) and end‐stage renal disease (ESRD) and is strongly associated with mortality in …

Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone …

O Vardeny, DH Wu, A Desai, P Rossignol… - Journal of the American …, 2012 - jacc.org
Objectives: This study investigated the influence of baseline and worsening renal function
(WRF) on the efficacy of spironolactone in patients with severe heart failure (HF) …

Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease

SG Coca, HM Krumholz, AX Garg, CR Parikh - Jama, 2006 - jamanetwork.com
ContextPatients with renal disease are at high risk for cardiovascular mortality. Determining
which interventions best offset this risk remains a health priority. ObjectiveTo quantify the …